These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17168371)

  • 1. [Ductal cytofluorometry of urine sediment level in the diagnosis of bladder cancer].
    Kaprin AD; Bozhenko VK; Kulinich TM; Nesterov PV; Kostin AA
    Vopr Onkol; 2006; 52(5):579-81. PubMed ID: 17168371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ductal cytometry of urinary sediment in the diagnosis of bladder cancer].
    Bozhenko BK; Kaprin AD; Kulinich TM; Nesterov PV
    Vopr Onkol; 2009; 55(3):278-84. PubMed ID: 19670726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of flow cytometry in diagnosis of urinary bladder cancer].
    Bozhenko VK; Kaprin AD; Kostin AA; Kulinich TM; Kudinova EA; Chazova NL; Mel'nikova NV; Nesterov PV
    Vopr Onkol; 2007; 53(4):468-72. PubMed ID: 17969413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the predictive value of UroVysion and AURKA FISH tests of urine sediment cells for the diagnosis of bladder cancer].
    Vorobtsova IE; Kouzova ED; Kolesnikova IS
    Vopr Onkol; 2013; 59(4):483-6. PubMed ID: 24032224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of bladder carcinoma].
    Mantur M; Jakubowska I; Kemona H
    Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of urinary cytology in the diagnosis and followup of bladder tumors. Review of 200 cases].
    el Mezni F; Chebil M; Belhassine S; Zermani R; Jemni M; Ennigrou S; Ayed M; Ben Jilani S
    Tunis Med; 1998 Dec; 76(12):475-80. PubMed ID: 10093489
    [No Abstract]   [Full Text] [Related]  

  • 7. The masquerade of bladder cancer in situ as interstitial cystitis.
    Utz DC; Zincke H
    Trans Am Assoc Genitourin Surg; 1973; 65():64-5. PubMed ID: 4763513
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer analysis of atypical urothelial cells. I. Classification by supervised learning algorithms.
    Koss LG; Bartels PH; Bibbo M; Freed SZ; Sychra JJ; Taylor J; Wied GL
    Acta Cytol; 1977; 21(2):247-60. PubMed ID: 324216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer analysis of atypical urothelial cells. II. Classification by unsupervised learning algorithms.
    Koss LG; Bartels PH; Sychra JJ; Wied GL
    Acta Cytol; 1977; 21(2):261-5. PubMed ID: 324217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytohistological examination of the urine in diagnosis of neoplasms of the bladder. Considerations on 5 years of experience].
    Zolfanelli R; Conti P; Acanfora F; Barasolo E; Cagna G; Bollero E; Biroli E
    Minerva Urol; 1976; 28(4):161-6. PubMed ID: 798121
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bladder cancer: diagnosis and prognosis--molecularbiological approach for prognostic factors. Discussion].
    Nihon Hinyokika Gakkai Zasshi; 1995 Jan; 86(1):55-65. PubMed ID: 7897922
    [No Abstract]   [Full Text] [Related]  

  • 13. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H; Kor K; Djalali M
    Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S; Zohny SF; Swellam M; Mahmoud MH; El-Zayat TM; Salem AM
    Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
    Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
    Lotan Y; Shariat SF;
    BJU Int; 2008 Jun; 101(11):1362-7. PubMed ID: 18284410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
    Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
    Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of microscopic study of the urine in the diagnosis of bladder cancer].
    Blokh MIa; Goznyĭ AD
    Lab Delo; 1968; 6():364-5. PubMed ID: 4184653
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary calreticulin in the diagnosis of bladder urothelial carcinoma.
    Kageyama S; Isono T; Matsuda S; Ushio Y; Satomura S; Terai A; Arai Y; Kawakita M; Okada Y; Yoshiki T
    Int J Urol; 2009 May; 16(5):481-6. PubMed ID: 19389084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.